Report error Found 89 Enz. Inhib. hit(s) with all data for entry = 13295
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Ligand Info

















































